Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q3 2020 Earnings
ELVN
5
Nov
Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-4.31
-2.87
-1.44
0
Details
Expected EPS
-0.8
Actual EPS
-0.72
Surprise EPS
0.08
Surprise Percent
+10%
Description
Enliven Therapeutics (ELVN) has reported earnings of -0.72 per share for Q3 2020.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login